Synta Pharmaceuticals Corp. (SNTA) Reports In-Line Q1 EPS of ($0.27)
Tweet Send to a Friend
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) reported Q1 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
